| Ministry Hc Hospice Stevens Point 2501 Main St Suite A, Stevens Point, WI, 54481 | |
| (715) 346-5355 |
News Archive
A Purdue University scientist is urging federal officials to decide whether genetically engineered salmon would be allowed for U.S. consumption and arguing that not doing so may set back scientific efforts to increase food production.
The risk of stroke or systemic embolism is significantly increased in atrial fibrillation patients with just one risk factor apart from gender, say researchers.
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS), will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology (AAN) in New Orleans.
› Verified 2 days ago
| Name | Ministry Hc Hospice Stevens Point |
|---|---|
| Location | 2501 Main St Suite A, Stevens Point, Wisconsin |
| Hospice ID | 521532 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 480 |
News Archive
A Purdue University scientist is urging federal officials to decide whether genetically engineered salmon would be allowed for U.S. consumption and arguing that not doing so may set back scientific efforts to increase food production.
The risk of stroke or systemic embolism is significantly increased in atrial fibrillation patients with just one risk factor apart from gender, say researchers.
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS), will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology (AAN) in New Orleans.
› Verified 2 days ago
| NPI Number | 1376586701 |
| Organization Name | Ministry Home Care, Llc. |
| Address | 2501 Main Street Stevens Point, Wisconsin, 54481 |
| Phone Number | (715)346-5355 |
News Archive
A Purdue University scientist is urging federal officials to decide whether genetically engineered salmon would be allowed for U.S. consumption and arguing that not doing so may set back scientific efforts to increase food production.
The risk of stroke or systemic embolism is significantly increased in atrial fibrillation patients with just one risk factor apart from gender, say researchers.
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS), will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology (AAN) in New Orleans.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.6 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.2 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 98.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 90.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.2 | 97.3 |
| Patients who got timely treatment for shortness of breath | 96.5 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 95.4 | 93.3 |
News Archive
A Purdue University scientist is urging federal officials to decide whether genetically engineered salmon would be allowed for U.S. consumption and arguing that not doing so may set back scientific efforts to increase food production.
The risk of stroke or systemic embolism is significantly increased in atrial fibrillation patients with just one risk factor apart from gender, say researchers.
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS), will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology (AAN) in New Orleans.
› Verified 2 days ago
| Home Health Aides | 5 |
| Counselors | 1 |
| Medical Social Workers | 4 |
| Physicians | 1.3 |
| Registered Nurses | 8 |
| Total Employees | 19.3 |
|---|
News Archive
A Purdue University scientist is urging federal officials to decide whether genetically engineered salmon would be allowed for U.S. consumption and arguing that not doing so may set back scientific efforts to increase food production.
The risk of stroke or systemic embolism is significantly increased in atrial fibrillation patients with just one risk factor apart from gender, say researchers.
A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS), will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology (AAN) in New Orleans.
› Verified 2 days ago
| Ministry Hc Hospice Stevens Point Location: 2501 Main St Suite A, Stevens Point, Wisconsin, 54481 Phone: (715) 346-5355 |